A case of response to combination treatment with autologous immunotherapy and bevacizumab in advanced non-small cell lung cancer

Natural killer (NK) cells have developed as a potent tool in cancer immunotherapy. Especially, patients who have failed in the first-line or maintenance treatment received a good response with immunotherapy in association with other approaches. We report the case of a 61-year-old male patient with p...

Descripció completa

Dades bibliogràfiques

Autors principals:	Thuy Mau Thi Nguyen, Khanh Van Tran, Van Thanh Ta, Linh Mai Tran, Chi Khanh Tran, Huy Le Trinh, Dat Thanh Ta, Binh Thanh Nguyen, Thinh Huy Tran
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-01-01
Col·lecció:	Respiratory Medicine Case Reports
Matèries:	Non-small cell lung cancer (NSCLC) Programmed cell death ligand - 1 (PD-L1) expression Autologous natural killer cells Bevacizumab
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S221300712200226X
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!